CAS No. 34031-32-8
Chemical Information
| CAS Number | 34031-32-8 | |
|---|---|---|
| Molecular Formula |
C20H34AuO9PS |
|
| Molecular Weight (MW) | 678.48 | |
| SMILES | CCP(CC)CC.CC(=O)OCC1C(C(C(C(O1)[S-])OC(=O)C)OC(=O)C)OC(=O)C.[Au+] |
Biological Activity
Auranofin is an FDA-approved, gold-containing inhibitor of thioredoxin reductase (TrxR) that displays antineoplastic and antibacterial activities. By inhibiting TrxR, auranofin disrupts intracellular redox homeostasis, leading to increased reactive oxygen species accumulation, mitochondrial dysfunction, and activation of apoptotic signaling pathways in cancer cells. Additionally, target inhibition impairs bacterial redox defenses, resulting in targeted disruption of bacterial survival and broad-spectrum bactericidal toxicity. [1][2]
How to Prepare Stock Solution?
|
Concentration
Volume
Mass
|
|---|
Solubility
| Solvent | Solubility & Note |
|---|---|
| DMSO |
100 mg/mL
(147.38 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Ethanol | 100 mg/mL |
| Water | Insoluble |
- Preheat media/saline to 37°C.
- Mix rapidly (pipette/vortex) upon addition.
- For complex mixes, always add the aqueous phase last.
- Re-dissolve minor precipitates with a 37°C water bath and sonication (≤30 min).

Pre-aliquoted for Longevity: Solid-state aliquots offer longer shelf life compared to stock solutions.
Looking for a specific aliquot size? Contact your local sales representative or orders@selleckchem.com.
Reference
Jump to
- Auranofin (SKF-39162) Clinical Trials
- Auranofin (SKF-39162) Solubility in DMSO
- Auranofin (SKF-39162) Stock Solution
- Auranofin (SKF-39162) Storage
- Auranofin (SKF-39162) Stability
- Auranofin (SKF-39162) Molecular Weight
- Auranofin (SKF-39162) SMILES
- Auranofin (SKF-39162) Chemical Structure (2D and 3D)
- Auranofin (SKF-39162) SDS|MSDS